Efficacy of Intravenous Tissue-type Plasminogen Activator on Acute Ischemic Stroke Patients With Large Vessel Occlusions
Reperfusion Rates of Intravenous Tissue-type Plasminogen Activator on Acute Ischemic Stroke Patients With Large Vessel Occlusions and Predictor Factors of Recanalization
Sponsor: University of Medicine and Pharmacy at Ho Chi Minh City
Listed as NCT04170647, this observational or N/A phase trial focuses on Stroke, Acute and Stroke, Ischemic and remains ongoing. Sponsored by University of Medicine and Pharmacy at Ho Chi Minh City, it has been updated 6 times since 2017, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
6 versions recorded-
Sep 2024 — Present [monthly]
Unknown
-
Jul 2024 — Sep 2024 [monthly]
Unknown
Status: Unknown Status → Unknown
-
Jan 2022 — Jul 2024 [monthly]
Unknown Status
Status: Recruiting → Unknown Status
-
Oct 2021 — Jan 2022 [monthly]
Recruiting
-
Jan 2021 — Oct 2021 [monthly]
Recruiting
▶ Show 1 earlier version
-
Dec 2019 — Jan 2021 [monthly]
Recruiting
First recorded
Oct 2017
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- University of Medicine and Pharmacy at Ho Chi Minh City
For direct contact, visit the study record on ClinicalTrials.gov .